Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Case Report
Author Details :
Volume : 4, Issue : 3, Year : 2019
Article Page : 277-278
https://doi.org/10.18231/j.achr.2019.050
Abstract
Introduction: Chromoblastomycosis is a chronic skin and subcutaneous mycotic infection caused by
pigmented or dematiaceous saprophytic fungi. The most common sites being upper and lower extremities
following any trauma. This paper reports a rare case of chromoblastomycosis in maxillary sinus.
Case Report: The patient was a 34 years old farmer who presented with nasal discharge and epistaxis for
the last 15 days. Following examination, the polyp was excised and sent for histopathological examination
which was diagnosed as chromoblastomycosis.
Conclusion: Chromoblastomycosis presenting as a nasal mass is a very rare entity and is usually mistaken
for granulomatous conditions. Histopathological examination along with culture for fungal organisms
could aid in the detection of species and effective management.
Keywords: Chromoblastomycosis, Maxillary sinus, Copperpennies, Medlar bodies.
How to cite : Nandish V S, A case of chromoblastomycosis in maxillary sinuses. IP Arch Cytol Histopathol Res 2019;4(3):277-278
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.